Contributors and Reviewers
Contributors
The findings and conclusions in this document are those of the contributors and reviewers. The contributors and reviewers participated as individuals and not necessarily as representatives of their organizations. No statement in this document should be construed as an official position of any organization represented here.
* Chapter Coordinator
1. Patient Registries
*Richard E. Gliklich, M.D.
Chief Executive Officer and Chairman
OM1
Boston, MA
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1
Boston, MA
2. Planning a Registry
Thomas Gross, M.D., M.P.H.
Director, Office of Surveillance and Biometrics
Center for Devices and Radiological Health
U.S. Food and Drug Administration
Silver Spring, MD
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1
Boston, MA
3. Registry Design
Nancy A. Dreyer, Ph.D., M.P.H., FISPE
Chief Scientific Officer
IQVIA Real-World & Analytic Solutions
Cambridge, MA
Hesha J. Duggirala, Ph.D., M.P.H.
Senior Epidemiologist, Office of Surveillance and Compliance
Center for Veterinary Medicine
U.S. Food and Drug Administration
Silver Spring, MD
*Vandana Menon, M.D.
Vice President, Research
OM1
Boston, MA
4. Selecting and Defining Outcome Measures for Registries
Richard E. Gliklich, M.D.
Chief Executive Officer and Chairman
OM1
Boston, MA
*Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1
Boston, MA
5. Data Elements for Registries
Irene Katzan, M.D., M.S.
Director, Neurological Institute Center for Outcomes Research & Evaluation
Cleveland Clinic Foundation
Cleveland, OH
*Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1
Boston, MA
Christina Mack, Ph.D., M.S.P.H.
Sr. Director, Epidemiology and Clinical Evidence; Head, Injury Surveillance and Analytics
IQVIA Real-World & Analytic Solutions
Chapel Hill, NC
John Spertus, M.D., M.P.H., FACC, FAHA
Director of CV Education and Outcomes Research
Saint Luke's Hospital
Kansas City, MS
6. Data Sources
Fang Li, M.D.
Formerly Sr. Director, Clinical Informatics
OM1
Boston, MA
*Keith Marsolo, Ph.D.
Associate Professor, Department of Population Health Sciences
Member, Duke Clinical Research Institute
Duke University School of Medicine
Durham, NC
7. Principles of Registry Ethics, Data Ownership, and Privacy
*Jiayan Chen, J.D.
Partner
McDermott Will & Emery LLP
Washington, DC
Andy DeMayo, J.D.
Senior Counsel and Head, Strategic Partnerships
OM1
Boston, MA
Deepali Doddi, J.D.
Associate
McDermott Will & Emery LLP
Chicago, IL
Scott A. Weinstein, J.D.
Partner
McDermott Will & Emery LLP
Washington, DC
8. Informed Consent
*Jessica Berg, J.D., M.P.H.
Dean, School of Law; Tom J.E. and Bette Lou Walker Professor of Law; Professor of Bioethics & Public Health
Case Western Reserve University
Cleveland, OH
9. Registry Governance
*Nancy A. Dreyer, Ph.D., M.P.H., FISPE
Chief Scientific Officer
IQVIA Real-World & Analytic Solutions
Cambridge, MA
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1
Boston, MA
10. Recruiting and Retaining Participants in the Registry
*Richard E. Gliklich, M.D.
Chief Executive Officer and Chairman
OM1
Boston, MA
Ralph G. Brindis, M.D., M.P.H., MACC, FSCAI
Clinical Professor of Medicine, Department of Medicine & the Philip R. Lee Institute for Health Policy Studies
University of California, San Francisco
Senior Medical Officer, External Affairs – ACC National Cardiovascular Registry
San Francisco, CA
Robert E. Harbaugh, M.D., FAANS, FACS, FAHA
Senior Vice President, Penn State Health; Distinguished Professor and Chair, Department of Neurosurgery; Professor, Department of Engineering Science and Mechanics
Penn State University, M.S. Hershey Medical Center
Hershey, PA
11. Obtaining Data and Quality Assurance
*Keith Marsolo, Ph.D.
Associate Professor in Population Health Sciences
Duke University School of Medicine
Durham, NC
Richard E. Gliklich, M.D.
Chief Executive Officer and Chairman
OM1
Boston, MA
12. Adverse Event Detection, Processing, and Reporting
Nancy A. Dreyer, M.P.H., Ph.D.
Chief Scientific Officer
IQVIA Real-World & Analytic Solutions
Cambridge, MA
Richard E. Gliklich, M.D.
Chief Executive Officer and Chairman
OM1
Boston, MA
*Marnie Hall, Ph.D., M.P.H., M.A.
Vice President, Center for Advanced Evidence Generation
IQVIA
Washington, DC
13. Analysis, Interpretation, and Reporting of Registry Data To Evaluate Outcomes
Nancy A. Dreyer, M.P.H., Ph.D.
Chief Scientific Officer
IQVIA Real-World & Analytic Solutions
Cambridge, MA
*Zhaohui Su, Ph.D.
Vice President, Biostatistics
OM1
Boston, MA
14. Assessing Quality
Nancy A. Dreyer, M.P.H., Ph.D.
Chief Scientific Officer
IQVIA Real-World & Analytic Solutions
Cambridge, MA
Richard E. Gliklich, M.D.
Chief Executive Officer and Chairman
OM1
Boston, MA
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
Previous Edition Contributors
We would also like to acknowledge the authors who contributed to previous editions of the User’s Guide. These authors are listed below in alphabetical order:
Amy P. Abernethy, M.D.
Susan Adams, J.D.
Fred Anderson, Ph.D.
Anthony L. Asher, M.D., FACS
Landen Bain
Ethan Basch, M.D., M.Sc.
Marc L. Berger, M.D.
Maya A. Bernstein, J.D.
Stella Blackburn, M.B., B.S., M.Sc., FRCP (Edin), FISPE
Jaclyn L. F. Bosco, Ph.D., M.P.H.
Brian D. Bradbury, M.A., D.Sc.
Jeanette M. Broering, R.N., Ph.D., M.P.H.
Laura D. Buccini, Dr.P.H., M.P.H.
Christina Chambers, Ph.D., M.P.H.
J. Alexander Cole, D.Sc., M.P.H.
Deborah Covington, Dr.P.H.
Janet D. Cragan, M.D., M.P.H.
David C. Dale, M.D.
Andy DeMayo, J.D.
Wei Dong, M.D., Ph.D.
Paul Eggers, Ph.D.
Alexander Elbert, Ph.D.
Benjamin C. Eloff, Ph.D.
Sara A. Ephross, Ph.D.
Sarah Garner, Ph.D., B.Pharm., M.R.Pharm.S.
Eric Gemmen, M.A.
Lisa Griffin Vincent, M.A., Ph.D.
Melissa M. Goldstein, J.D.
Stephen C. Groft, Pharm.D.
Stephen E. Fienberg, Ph.D., FRSC
Joanna Haas, M.D., M.Sc.
Melanie J. Harrison, M.D., M.S.C.E.
Sonia Hernández-Díaz, M.D., M.P.H., Dr.P.H.
Adrian F. Hernandez, M.D., M.H.S.
Kathleen Hewitt, M.S.N., R.N., A.A.C.C.
Holly L. Howe, Ph.D.
Alan F. Karr, Ph.D.
David W. Kaufman, Sc.D.
Stuart Kim, J.D., M.S.
James K. Kirklin, M.D.
Catherine Koepper
Joel M. Kremer, M.D.
Harlan M. Krumholz, M.D., S.M.
Kimary Kulig, Ph.D., M.P.H.
Richard E. Kuntz, M.D., M.Sc
Debra R. Lappin, J.D.
Timothy L. Lash, D.Sc., M.P.H.
Daniel Levy, M.S.
David J. Malenka, M.D.
Bradley Malin, Ph.D.
Keith Mandel, M.D.
Neal Mantick, M.S.
Danica Marinac-Dabic, M.D., Ph.D.
Bruce C. Marshall, M.D.
David Matcher, M.D.
C. Geoffrey McDonough
Benjamin Miriovsky, M.D.
Barry Mirrer, M.S., CMQ/OE
David C. Naftel, Ph.D.
Sharon-Lise T. Normand, Ph.D.
Elizabeth Paxton, M.A.
Eric Peterson, M.D., M.P.H.
Rachel L. Richesson, Ph.D., M.P.H.
Sara Rosenbaum, J.D.
Kenneth J. Rothman, Dr.P.H.
Yaffa Rubinstein, Ph.D.
Gregory Samsa, Ph.D.
Gillian D. Sanders, Ph.D.
Lee H. Schwamm, M.D., FAHA
Art Sedrakyan, M.D., Ph.D.
David M. Shahian, M.D.
Neha Sheth, Pharm.D.
Henrik Toft Sørensen, M.D., Ph.D., Dr.Med.Sci.
Paul Stang, Ph.D.
Kathryn Starzyk, Sc.M.
Charlie Strange, M.D.
Michelle Tarver, M.D., Ph.D.
Melissa S. Tassinari, Ph.D.
Dale R. Tavris, M.D., M.P.H.
Joseph Terdiman, M.D., Ph.D.
Jane Hyatt Thorpe, J.D.
Stephen Toovey, M.D., Ph.D.
Anne E. Trontell, M.D., M.P.H.
Priscilla Velentgas, Ph.D.
Marianne Ulcickas Yood, D.Sc., M.P.H.
Reviewers
The findings and conclusions in this document are those of the contributors and reviewers. The contributors and reviewers participated as individuals and not necessarily as representatives of their organizations. No statement in this document should be construed as an official position of any organization represented here.
Amisha Barochia, M.B.B.S., M.H.S.
Staff Clinician
National Heart, Lung, and Blood Institute
Bethesda, MD
Regan W. Bergmark, M.D.
Associate Surgeon, Otolaryngology-Head and Neck Surgery
Patient Reported Outcomes, Value and Experience (PROVE) Center; Center for Surgery and Public Health
Brigham and Women’s Hospital
Instructor, Department of Otolaryngology, Harvard Medical School
Boston, MA
Seth Blumenthal, M.B.A.
Director, Clinical Review Group, Integrated Health Model Initiative
American Medical Association
Chicago, IL
Allison Bryant, M.P.H.
Epidemiologist
OM1
Boston, MA
Gary Curhan, M.D., Sc.D.
Professor of Medicine, Harvard Medical School
Professor, Department of Epidemiology, Harvard T.H. Chan School of Public Health
Boston, MA
Nancy A. Dreyer, M.P.H., Ph.D.
Chief Scientific Officer
IQVIA Real-World & Analytic Solutions
Cambridge, MA
Paula DiStabile, R.N., M.S.N., J.D.
Health Scientist Administrator
Center for Quality Improvement and Patient Safety (CQuIPS)
Agency for Healthcare Research and Quality
Rockville, MD
Chris Crowe, Ph.D.
National Mental Health Director-Psychotherapy
Office of Mental Health and Suicide Prevention
U.S. Department of Veterans Affairs
Washington, DC
Diane Cousins, R.Ph.
Center for Quality Improvement and Patient Safety (CQuIPS)
Agency for Healthcare Research and Quality
Rockville, MD
Andy DeMayo, J.D.
Senior Counsel and Head, Strategic Partnerships
OM1
Boston, MA
Richard E. Gliklich, M.D.
Chief Executive Officer and Chairman
OM1
Boston, MA
Julia G. Gorey, J.D.
Executive Director, SACHRP
U.S. Department of Health and Human Services
Rockville, MD
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
Daniel Levy, M.S.
Vice President, Data Solutions
OM1
Boston, MA
Theodore Lystig, Ph.D.
Director, Corporate Biostatistics, Strategic & Scientific Operations
Medtronic
Minneapolis, MN
Elisha Malanga, M.S.
Chief Research Officer
COPD Foundation
Washington, DC
Sonia Maruti, Ph.D.
Director of Epidemiology
Sanofi Genzyme
Cambridge, MA
Aaron B. Mendelsohn, Ph.D., M.P.H.
Research Scientist, Department of Population Medicine
Harvard Medical School and Harvard Pilgrim Health Care Institute
Boston, MA
Vandana Menon, M.D.
Vice President, Research
OM1
Boston, MA
Sanghamitra Mohanty, M.D., M.S., FHRS
Director, Translational Research
Texas Cardiac Arrhythmia Institute
Austin, TX
Kathleen Mortimer, Ph.D.
Director of Epidemiology
OM1
Boston, MA
Marissa Gordon-Nguyen, J.D.
Senior Advisor for HIPAA Policy, Office for Civil Rights
U.S. Department of Health and Human Services
Washington, D.C.
Bryan Olin, Ph.D.
Senior Vice President, Clinical, Quality Assurance & Regulatory Affairs
LivaNova PLC
London, UK
Sarah Rittner, M.A.
Director of Operations, Center for Health Equity Transformation
Northwestern University
Chicago, IL
Kathryn Starzyk, Sc.M.
Senior Director, Real-World Evidence
OM1
Boston, MA
Zhaohui Su, Ph.D.
Vice President, Biostatistics
OM1
Boston, MA
Paul Wallace, M.D.
Senior Scholar
AcademyHealth
Washington, DC
David S. Wendler, M.A., Ph.D.
Head, Unit on Vulnerable Populations, Department of Bioethics
National Institutes of Health Clinical Center
Bethesda, MD
Albert Wu, M.D., M.P.H.
Professor of Health Policy and Management; Director, Center for Health Services and Outcomes Research
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD
Previous Edition Reviewers
We would also like to acknowledge the reviewers who contributed to previous editions of the User’s Guide. These reviewers are listed below in alphabetical order:
Susan Adams, J.D.
Paul S. Appelbaum, M.D.
Diane J. Aschman, M.S.
Steven J. Atlas, M.D., M.P.H.
Stephen W. Bernstein, J.D.
Marcella Blackledge, B.A.
Kathleen Blake, M.D., M.P.H.
Jaclyn L. F. Bosco, Ph.D., M.P.H.
Jeanette M. Broering, R.N., Ph.D., M.P.H.
Jeffrey Brown, Ph.D.
Daniel Caños
Michael A. Carome, M.D.
J. Alexander Cole, D.Sc., M.P.H.
Jack L. Cronenwett, M.D.
Jay Crowley
Theresa Cullen, M.D., M.S.
David C. Dale, M.D.
Leonard D’Avolio, Ph.D.
Joseph A.C. Delaney, Ph.D.
Patrice Desvigne-Nickens, M.D.
Douglas S. Diekema, M.D., M.P.H.
Rachel S. Dokholyan, M.P.H.
Pamela S. Douglas, M.D., FACC
Joseph P. Drozda, Jr., M.D., FACC
Hesha J. Duggirala, Ph.D., M.P.H.
Brenda K. Edwards, Ph.D.
Paul Eggers, Ph.D.
Jonathan S. Einbinder, M.D., M.P.H.
Benjamin C. Eloff, Ph.D.
Barbara Evans, J.D., Ph.D.
Shamiram Feinglass, M.D., M.P.H.
T. Bruce Ferguson, M.D., FAHA
Leslye K. Fitterman, Ph.D.
Sally Flanzer, Ph.D., CIP
Mark J. Fox
Lori Frank, Ph.D.
Gregg C. Fonarow, M.D.
Sarah Garner, Ph.D., B.Pharm., M.R.Pharm.S.
Yvonne Geissbuehler, Ph.D.
Eric Gemmen, M.A.
Julian M. Goldman, M.D.
Marissa Gordon-Nguyen, J.D.
Julia G. Gorey, J.D.
Marie R. Griffin, M.D., M.P.H.
Thomas Gross, M.D., M.P.H.
Claudia Grossmann, Ph.D.
Joanna Haas, M.D., M.Sc.
Rosemarie Hakim, Ph.D.
John D. Halamka, M.D., M.S.
Stephen C. Hammill, M.D.
Melanie J. Harrison, M.D., M.S.C.E.
Christina M. Heide, J.D.
Kathleen Hewitt, M.S.N., R.N., A.A.C.C., CPHQ
Janet Hiller, M.P.H., Ph.D.
Barrie J. Hurwitz, M.B., MRCP
Michael Ibara, Pharm.D.
Solomon Iyasu, M.D., M.P.H.
Emma James, Ph.D.
Robert A. Jenders, M.D., M.S., FACP, FACMI
Peter I. Juhn, M.D., M.P.H.
Michael Kahn, M.D., Ph.D.
Clifford Ko, M.D.
Catherine Koepper
Rebecca D. Kush, Ph.D.
Joseph A. Ladapo, M.D., Ph.D.
Julia I. Lane
Wendy Lipworth, M.D., Ph.D.
Peter Littlejohns, M.D.
Danica Marinac-Dabic, M.D., Ph.D.
Bruce C. Marshall, M.D.
Susan McAndrew, J.D.
Newell McElwee, Pharm.D., M.S.P.H.
J. Michael McGinnis, M.D., M.P.P.
Deven McGraw, J.D., M.P.H., L.L.M.
Charles R. McKay, M.D., FACC
Aaron B. Mendelsohn, Ph.D., M.P.H.
Marissa A. Miller, D.V.M., M.P.H.
Barry Mirrer, M.S., CMQ/OE
Kristi R. Mitchell, M.P.H.
Lawrence H. Muhlbaier, Ph.D.
Barbara Muth
David C. Naftel, Ph.D.
Steven E. Nissen, M.D.
J. Marc Overhage, M.D., Ph.D.
Dimitrios Pappas, M.D., M.P.H.
Gareth Parry, Ph.D.
Steven Pearson, M.D.
Eric Peterson, M.D., M.P.H.
Steve E. Phurrough, M.D., M.P.A.
Richard Platt, M.D., M.Sc.
Richard L. Prager, M.D.
Victoria M. Prescott, J.D.
Michael T. Rapp, M.D., J.D., FACEP
Robert Reynolds, Sc.D.
Gerald F. Riley, M.S.P.H.
Sara Rosenbaum, J.D.
Kenneth J. Rothman, Dr.P.H.
Yaffa Rubinstein, Ph.D.
Patricia Russo, Ph.D.
Susan T. Sacks, Ph.D.
Grannum Sant, M.D., FRCS, FACS
Brian C. Sauer, Ph.D., M.S.
William B. Saunders, Ph.D., M.P.H.
Judy A. Staffa, Ph.D., R.Ph.
Juergen Schmider, M.D., Ph.D.
Art Sedrakyan, M.D., Ph.D.
James G. Snell, J.D.
Paul Stang, Ph.D.
Michael Steinbuch, Ph.D.
Walter L. Straus, M.D., M.P.H.
Elizabeth J. Swain
Michelle Tarver, M.D., Ph.D.
Hugh Tilson, M.D., M.P.H., Dr.P.H.
Anne E. Trontell, M.D., M.P.H.
Kelly Trout, B.S.N., R.N.
Jack V. Tu, M.D., Ph.D.
Paul D. Varosy, M.D.
Priscilla Velentgas, Ph.D.
Cunlin Wang, M.D., Ph.D.
Jennifer Weisman, Ph.D.
Suzanne L. West, M.P.H., Ph.D.
Marcy Wilder, J.D.
Marcus D. Wilson, Pharm.D.
Albert Wu, M.D., M.P.H.
John Yee, M.D., M.P.H.
Case Example Contributors
The findings and conclusions in this document are those of the contributors and reviewers. The contributors and reviewers participated as individuals and not necessarily as representatives of their organizations. No statement in this document should be construed as an official position of any organization represented here.
1. Creating a Registry To Fulfill Multiple Purposes and Using a Publications Committee To Review Data Requests
Edna Stoehr
Global Study Manager
Genentech, Inc.
South San Francisco, CA
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
2. Determining When To Stop an Open-Ended Registry
Jessica Albano, Ph.D., M.P.H.
Executive Director, Epidemiology & Health Outcomes
Syneos Health Clinical Solutions
Sewickley, PA
Ann Mallard, M.P.H.
Executive Director, Non-interventional Studies
Evidera
Wilmington, NC
Pattra Mattox, S.M.
Senior Manager
Aetion
Boston, MA
3. Modifying a Registry Due To Changes in Standards of Care
Dawn Eng, R.N., B.S.N.
Formerly Senior Clinical Trial Head, Oncology Global Medical Affairs
Novartis Pharmaceuticals Corporation
East Hanover, NJ
Alexandra Parnell, M.S.
Regulatory Affairs Manager, Real World Analytics Solutions
IQVIA
Boston, MA
4. Using Registries To Understand Rare Diseases
Betsy Bogard, M.S.
Head of Real-World Evidence
bluebird bio
Cambridge, MA
Catherine Koepper
Vice President, Head of Alliance Management
Sanofi Genzyme
Cambridge, MA
Nicole Robichaud
Senior Project Manager, Global Registry Program
Sanofi Genzyme
Cambridge, MA
John Yee, M.D., M.P.H.
Senior VP, Medical Affairs
Flexion Therapeutics
Burlington, MA
5. Using a Registry To Assess Long-Term Product Safety
Pattra Mattox, S.M.
Senior Manager
Aetion
Boston, MA
Deborah Symmons, M.D.
Professor of Rheumatology and Musculoskeletal Epidemiology (retired)
University of Manchester
Manchester, United Kingdom
Kimme Hyrich, M.D., Ph.D., F.R.C.P.C.
Professor of Epidemiology and Honorary Consultant in Rheumatology
Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health
The University of Manchester
Manchester, United Kingdom
6. Expanding an Ongoing Pregnancy Registry
Jessica Albano, Ph.D., M.P.H.
Executive Director, Epidemiology & Health Outcomes
Syneos Health Clinical Solutions
Sewickley, PA
Deborah Covington, Dr.P.H.
Senior Research Leader, Real-World Evidence
Evidera
Wilmington, NC
7. Designing a Registry To Address Unique Patient Enrollment Challenges
Karen Domino, M.D., M.P.H.
Professor, Department of Anesthesiology and Pain Medicine
University of Washington
Seattle, WA
Laura Khurana, M.P.H.
Senior Scientific Advisor
ERT
Boston, MA
Karen L. Posner, Ph.D.
Research Professor, Department of Anesthesiology and Pain Medicine
University of Washington
Seattle, WA
8. Using Registries To Drive Quality Improvement in Chronic Conditions
Pattra Mattox, S.M.
Senior Manager
Aetion
Boston, MA
Peter Schmidt, Ph.D.
Senior Vice President, Chief Research & Clinical Officer
National Parkinson’s Foundation
Miami, FL
9. Developing and Validating a Patient-Administered Questionnaire
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
Grannum Sant, M.D., FRCS, FACS
Formerly Vice President and Head, Oncology and Urology Medical Affairs, Sanofi-aventis U.S., Bridgewater, NJ
Adjunct Professor of Urology, Tufts University School of Medicine
Boston, MA
10. Using Validated Measures To Collect Patient-Reported Outcomes
Kathleen M. Fox, Ph.D., M.H.S.
President
Strategic Healthcare Solutions, LLC
Aiken, SC
Susan Grandy, Ph.D., M.B.A.
Senior Director, Global Product and Portfolio Strategy
AstraZeneca
Gaithersburg, MD
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
11. Using Recognition Measures To Develop a Dataset
Kenneth A. LaBresh, M.D.
Senior Fellow
RTI International
Waltham, MA
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
Louise Morgan, M.S.N., CPHQ
Director, International Quality Improvement
American Heart Association
Scotch Plains, NJ
Lee H. Schwamm, M.D., FAHA
Executive Vice Chairman, Department of Neurology; C. Miller Fisher Endowed Chair; Director, MGH Stroke Services
Massachusetts General Hospital; Professor of Neurology, Harvard Medical School
Boston, MA
12. Patient-Powered Registries: Developing Scalable and Reusable Infrastructure To Support Harmonised Data Collection Across Rare Diseases
Vanessa Boulanger, M.Sc.
Director of Research Programs
National Organization for Rare Disorders
Danbury, CT
Suzanne Rossov
Research Programs Manager
National Organization for Rare Disorders
Danbury, CT
Allison Seebald
Research Programs Manager
National Organization for Rare Disorders
Danbury, CT
13. Using Claims Data Along With Patient-Reported Data To Identify Patients
D. Kevin Horton, Dr.P.H., M.S.P.H.
Chief, Environmental Health Surveillance Branch
Agency for Toxic Substances & Disease Registry
Centers for Disease Control and Prevention
Atlanta, GA
Paul Mehta, M.D.
Medical Epidemiologist, Environmental Health Surveillance Branch
Agency for Toxic Substances & Disease Registry
Centers for Disease Control and Prevention
Atlanta, GA
Pattra Mattox, S.M.
Senior Manager
Aetion
Boston, MA
14. Using a Patient-Centred Study Design To Collect Informed Consent, Maximise Recruitment and Retention, and Provide Meaningful Clinical Data
Patricia D. Franklin, M.D., M.B.A., M.P.H.
Professor and Co-Director, Outcomes and Measurement Hub, Department of Medical Social Sciences
Northwestern University Feinberg School of Medicine; Senior Scientist, FORCE-TJR
Chicago, IL
Laura Khurana, M.P.H.
Senior Scientific Advisor
ERT
Boston, MA
15. Linking a Procedure-Based Registry With Claims Data To Study Long-Term Outcomes
Mark J. Fox
Privacy and Research Compliance Officer
American College of Cardiology
Washington, DC
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
16. Issues With Obtaining Informed Consent
Moira K. Kapral, M.D., M.Sc., FRCPC
Professor of Medicine, University of Toronto; Senior Scientist, ICES
Toronto, Canada
Janice A. Richards, R.N., B.A.
Formerly Project Manager
Registry of the Canadian Stroke Network
Toronto, Canada
Jack V. Tu, M.D., Ph.D.
Professor of Medicine, University of Toronto; Staff Physician, Sunnybrook Schulich Heart Centre; Senior Scientist, Institute for Clinical Evaluative Sciences
Toronto, Canada
17. Operationalising Informed Consent for Children
Catherine Birken, M.D., M.Sc., FRCPC
Associate Professor, Department of Pediatrics, University of Toronto
Staff Paediatrician, The Hospital for Sick Children; Associate Scientist, Hospital for Sick Children Research Institute
Toronto, Canada
Laura Khurana, M.P.H.
Senior Scientific Advisor
ERT
Boston, MA
Jonathon Maguire, M.D., M.Sc., FRCPC
Associate Professor of Paediatrics, University of Toronto; Scientist, Li Ka Shing Knowledge Institute
Department of Pediatrics, St. Michael’s Hospital
Toronto, Canada
Magda Nunes de Melo, B.Sc.Pharm., M.Sc.
Formerly Manager, Observational Epidemiology and Qualitative Research Unit
Applied Health Research Centre, St. Michael’s Hospital
Toronto, Canada
Patricia Parkin, M.D., FRCPC
Research Director, Division of Pediatric Medicine and the Pediatric Outcomes Research Team
The Hospital for Sick Children
Toronto, Canada
18. Obtaining a Waiver of Informed Consent
Mark J. Fox
Privacy and Research Compliance Officer
American College of Cardiology
Washington, DC
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
19. Developing a Public-Private Partnership for Comparative Effectiveness Research
Elise Berliner, Ph.D.
Director, Technology Assessment Program
Center for Evidence and Practice Improvement (CEPI)
Agency for Healthcare Research and Quality
Rockville, MD
Flora Lum, M.D.
Vice President, Quality and Data Science
American Academy of Ophthalmology
San Francisco, CA
Pattra Mattox, S.M.
Senior Manager
Aetion
Boston, MA
20. Developing a Patient-Centred Governance Structure
Ben Nowell, Ph.D.
Director, Patient-Centred Research
Global Healthy Living Foundation and Patient Powered Arthritis Research Network
Nyack, NY
21. Using Registry Tools To Recruit Sites
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
22. Using a Scientific Advisory Board To Support Investigator Research Projects
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
Michael D. Taylor, Pharm.D., Ph.D.
Global Head of Epidemiology for Oncology
Genentech, A Member of the Roche Group
South San Francisco, CA
23. Understanding Baseline Characteristics of Combined Datasets Prior to Analysis
Maria Inacio, M.S.
Epidemiologist, Surgical Outcomes and Analysis
Kaiser Permanente
San Diego, CA
Laura Khurana, M.P.H.
Senior Scientific Advisor
ERT
Boston, MA
Gregory B. Maletis, M.D.
Chief of Orthopedics, Baldwin Park Medical Center
Kaiser Permanente
Baldwin Park, CA
Elizabeth Paxton, M.A.
Director, Kaiser Permanente National Implant Registries
Southern California Permanente Medical Group
San Diego, CA
24. Using Registry Data To Evaluate Outcomes by Practice
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
Jeffrey Wagener, M.D.
Professor of Pediatrics
University of Colorado Medical School
Aurora, CO
25. Using Registry Data To Study Patterns of Use and Outcomes
Marnie L. Boron, Pharm.D.
Formerly Director, Scientific Communications
MedImmune
Gaithersburg, MD
Michelle B. Leavy, M.P.H.
Head, Healthcare Research and Policy
OM1, Inc.
Boston, MA
